Last reviewed · How we verify

Inactivated Enterovirus Type 71 Vaccine

Sinovac Biotech Co., Ltd · Phase 1 active Biologic

Inactivated Enterovirus Type 71 Vaccine is a Biologic drug developed by Sinovac Biotech Co., Ltd. It is currently in Phase 1 development. Also known as: EV71 Vaccine.

At a glance

Generic nameInactivated Enterovirus Type 71 Vaccine
Also known asEV71 Vaccine
SponsorSinovac Biotech Co., Ltd
ModalityBiologic
PhasePhase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Inactivated Enterovirus Type 71 Vaccine

What is Inactivated Enterovirus Type 71 Vaccine?

Inactivated Enterovirus Type 71 Vaccine is a Biologic drug developed by Sinovac Biotech Co., Ltd.

Who makes Inactivated Enterovirus Type 71 Vaccine?

Inactivated Enterovirus Type 71 Vaccine is developed by Sinovac Biotech Co., Ltd (see full Sinovac Biotech Co., Ltd pipeline at /company/sinovac-biotech-co-ltd).

Is Inactivated Enterovirus Type 71 Vaccine also known as anything else?

Inactivated Enterovirus Type 71 Vaccine is also known as EV71 Vaccine.

What development phase is Inactivated Enterovirus Type 71 Vaccine in?

Inactivated Enterovirus Type 71 Vaccine is in Phase 1.

Related